|
⚲
|
| Keyboard |
| Celentano John E
✚
|
|
|---|---|
| CIK # | 0001346102 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001346102] | |
| 4 | [0001346102] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| IGI Laboratories Inc | |
| Celentano John E | |
| Bristol Myers Squibb Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
IGI Laboratories Inc TLGT
Restricted Stock Units · derivative
|
2021-07-21 | Grant | 150,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2021-01-04 | Grant | 2,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2020-01-02 | Grant | 20,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2019-10-02 | Grant | 14,205 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2019-07-01 | Grant | 19,231 | $0.00 | |
|
IGI Laboratories Inc TLGT
Common Stock
|
2019-05-31 | Buy | 20,000 | $0.65 | 13,000 |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2019-05-13 | Grant | 14,535 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2019-05-13 | Grant | 14,535 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2019-01-02 | Grant | 20,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2018-01-02 | Grant | 20,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2017-01-03 | Grant | 20,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2016-01-04 | Grant | 20,000 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Performance Shares · derivative
|
2012-03-06 | Option exercise | 28,073 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2012-03-06 | Tax withheld | 1,683 | $32.33 | 54,411 |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2012-03-06 | Option exercise | 28,073 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2012-03-06 | Tax withheld | 9,469 | $32.33 | 306,133 |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2012-03-06 | Option exercise | 4,257 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Performance Shares · derivative
|
2012-03-06 | Grant | 10,010 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Performance Shares · derivative
|
2012-03-06 | Grant | 9,789 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Performance Shares · derivative
|
2012-03-06 | Other | 833.65 | $0.00 | |
| showing 20 of 38 most recent transactions | |||||